Results 131 to 140 of about 44,049 (225)

Are thrombosis, progression, and survival in ET predictable?

Blood Cancer Journal
Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T. Silver, Joseph M. Scandura   +7 more
doaj   +1 more source

On the prenatal origins of the myeloproliferative neoplasms. [PDF]

EXCLI J
Langabeer SE.
europepmc   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Molecular and Functional Platelet Abnormalities in Myeloproliferative Neoplasms. [PDF]

Cells
Wang AX, Guo BB, Linden MD.
europepmc   +1 more source

Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasms. [PDF]

Blood Neoplasia
Heaton WL, Jenkins MT, Arellano NS, Brown CT, Tantravahi SK, Elf SE.   +5 more
europepmc   +1 more source

Telehealth-Delivered Dietary Counseling in Myeloproliferative Neoplasms: A Randomized Feasibility Study. [PDF]

Nutrients
Fleischman A, Li J, Tabban A, Cai S, Odegaard A.   +4 more
europepmc   +1 more source

The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes. [PDF]

Curr Hematol Malig Rep
Fleischman AG.
europepmc   +1 more source

Myeloproliferative Neoplasm [PDF]

, 2020
openaire   +1 more source

Genomic characterization of spleens in patients with myelofibrosis

Haematologica, 2018
Eran Zimran, Joseph Tripodi, Raajit Rampal, Franck Rappoport, Sharon Zirkiev, Ronald Hoffman, Vesna Najfeld   +6 more
doaj   +1 more source

DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]

Ann Hematol
Arafat AMA, Ghaffar HAA, Khallaf AM, Younes SAM, Morad MA, Mahgoub SMA.   +5 more
europepmc   +1 more source